Skip to main content

Advertisement

SpringerLink
Log in

Impact of ABC transporters, glutathione conjugates in MDR and their modulation by flavonoids: an overview

  • Review Article
  • Published:
Medicinal Chemistry Research Aims and scope Submit manuscript

Abstract

Overexpression of ATP-binding cassette (ABC) transporter and glutathione conjugates results in efflux of cytotoxic agent from tumor cells leading to multidrug resistance (MDR). Many MDR inhibitors have been identified but none of them have been proven clinically valuable without side effects. Efforts are continue to develop an ideal MDR inhibitor. Recently, herbal modulation of ABC transporter and glutathione conjugates by flavonoids is emerging as popular therapy in MDR. In this review, we have covered structure, function of different ABC transporters and glutathione-mediated MRP overexpression. This review also focuses on the problems with existing MDR inhibitors, modulation of ABC transporter and glutathione-S-transferase by flavonoids.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  • Abolhoda A, Wilson AE, Ross H, Danenberg PV, Burt M, Scotto KW (1999) Rapid activation of MDR1 gene expression in human metastatic sarcoma after in vivo exposure to doxorubicin. Clin Cancer Res 5:3352–3356

    CAS  PubMed  Google Scholar 

  • Adachi M, Reid G, Schuetz JD (2002) Therapeutic and biological importance of getting nucleotides out of cells: a case for the ABC transporters, MRP4 and 5. Adv Drug Deliv Rev 54:1333–1342

    Article  CAS  PubMed  Google Scholar 

  • Ader P, Wessmann A, Wolffram S (2000) Bioavailability and metabolism of the flavonol quercetin in the pig. Free Radic Biol Med 28:1056–1067

    Article  CAS  PubMed  Google Scholar 

  • Ahmed-Belkacem A, Pozza A, Muñoz-Martínez F, Bates SE, Castanys S, Gamarro F, Pietro Di, APérez-Victoria JM (2005) Flavonoid structure-activity studies identify 6-prenylchrysin and tectochrysin as potent and specific inhibitors of breast cancer resistance protein ABCG2. Cancer Res 65:4852–4860

    Article  CAS  PubMed  Google Scholar 

  • Allikmets R, Schriml LM, Hutchinson A, Romano-Spica V, Dean M (1998) A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. Cancer Res 58:5337–5339

    CAS  PubMed  Google Scholar 

  • Altenberg GA (2004) Structure of multidrug-resistance proteins of the ATP-binding cassette (ABC) superfamily. Curr Med Chem 4:53–62

    CAS  Google Scholar 

  • Ambudkar SV, Dey S, Hrycyna CA, Ramachandra M, Pastan I, Gottesman MM (1999) Biochemical, cellular, and pharmacological aspects of the multidrug transporter 1. Annu Rev Pharmacol 39:361–398

    Article  CAS  Google Scholar 

  • Ambudkar SV, Kim IW, Sauna ZE (2006) The power of the pump: mechanisms of action of P-glycoprotein (ABCB1). Eur J Pharm Sci 27:392–400

    Article  CAS  PubMed  Google Scholar 

  • Assaraf YG, Rothem L, Hooijberg JH, Stark M, Ifergan I, Kathmann I, Dijkmans BAC, Peters GJ, Jansen G (2003) Loss of multidrug resistance protein 1 expression and folate efflux activity results in a highly concentrative folate transport in human leukemia cells. J Biol Chem 278:6680–6686

    Article  CAS  PubMed  Google Scholar 

  • Aszalos A (2008) Role of ATP-binding cassette (ABC) transporters in interactions between natural products and drugs. Curr Drug Metab 9:1010–1018

    Article  CAS  PubMed  Google Scholar 

  • Bansal T, Jaggi M, Khar R, Talegaonkar S (2009) Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy. J Pharm Pharm Sci 12:46–78

    CAS  PubMed  Google Scholar 

  • Bera TK, Lee S, Salvatore G, Lee B, Pastan I (2001) MRP8, a new member of ABC transporter superfamily, identified by EST database mining and gene prediction program, is highly expressed in breast cancer. Mol Med 7:509–516

    PubMed Central  CAS  PubMed  Google Scholar 

  • Bera TK, Iavarone C, Kumar V, Lee S, Lee B, Pastan I (2002) MRP9, an unusual truncated member of the ABC transporter superfamily, is highly expressed in breast cancer. Proc Natl Acad Sci 99:6997–7002

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Borst P, Elferink RO (2002) Mammalian ABC transporters in health and disease. Ann Rev Biochem 71:537–592

    Article  CAS  PubMed  Google Scholar 

  • Borst P, Evers R, Kool M, Wijnholds J (2000) A family of drug transporters: the multidrug resistance-associated proteins. J Natl Cancer Inst 92:1295–1302

    Article  CAS  PubMed  Google Scholar 

  • Boumendjel A, Beney C, Deka N, Mariotte AM, Lawson MA, Trompier D, Baubichon-Cortay H, Pietro AD (2002a) 4-Hydroxy-6-methoxyaurones with high-affinity binding to cytosolic domain of P-glycoprotein. Chem Pharm Bull 50:854–856

    Article  CAS  PubMed  Google Scholar 

  • Boumendjel A, Di Pietro A, Dumontet C, Barron D (2002b) Recent advances in the discovery of flavonoids and analogs with high-affinity binding to P-glycoprotein responsible for cancer cell multidrug resistance. Med Res Rev 22:512–529

    Article  CAS  PubMed  Google Scholar 

  • Boušová I, Skálová L (2012) Inhibition and induction of glutathione S-transferases by flavonoids: possible pharmacological and toxicological consequences. Drug Metabol Rev 44:267–286

    Google Scholar 

  • Boušová I, Hájek J, Dršata J, Skálová L (2012) Naturally occurring flavonoids as inhibitors of purified cytosolic glutathione S-transferase. Xenobiotica 42:872–879

    Article  PubMed  CAS  Google Scholar 

  • Bueno Pérez L, Pan L, Sass E, Gupta SV, Lehman A, Kinghorn ADLucas DM (2012) Potentiating effect of the flavonolignan (−)-hydnocarpin in combination with vincristine in a sensitive and P-gp-expressing acute lymphoblastic leukemia cell line. Phytother Res. doi:10.1002/ptr.4903

    PubMed  Google Scholar 

  • Buggins TR, Dickinson PA, Taylor G (2007) The effects of pharmaceutical excipients on drug disposition. Adv Drug Deliv Rev 59:1482–1503

    Article  CAS  PubMed  Google Scholar 

  • Castro AF, Altenberg GA (1997) Inhibition of drug transport by genistein in multidrug-resistant cells expressing P-glycoprotein. Biochem Pharmacol 53:89–93

    Article  PubMed  Google Scholar 

  • Choi CH (2005) ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal. Cancer Cell Int 5:30

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  • Comte G, Daskiewicz JB, Bayet C, Conseil G, Viornery-Vanier A, Dumontet C, Di Pietro A, Barron D (2001) C-Isoprenylation of flavonoids enhances binding affinity toward P-glycoprotein and modulation of cancer cell chemoresistance. J Med Chem 44:763–768

    Article  CAS  PubMed  Google Scholar 

  • Conseil G, Baubichon-Cortay H, Dayan G, Jault JM, Barron D, Di Pietro A (1998) Flavonoids: a class of modulators with bifunctional interactions at vicinal ATP-and steroid-binding sites on mouse P-glycoprotein. Proc Natl Acad Sci 95:9831–9836

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Crowley E, McDevitt CA, Callaghan R (2010) Generating inhibitors of P-glycoprotein: where to, now. Methods Mol Biol 596:405–432

    Article  CAS  PubMed  Google Scholar 

  • Dantzig A, Shepard R, Law K, Tabas L, Pratt S, Gillespie J, Binkley S, Kuhfeld M, Starling J, Wrighton S (1999) Selectivity of the multidrug resistance modulator, LY335979, for P-glycoprotein and effect on cytochrome P-450 activities. J Pharmacol Exp Ther 290:854–862

    CAS  PubMed  Google Scholar 

  • Day AJ, Bao Y, Morgan MRA, Williamson G (2000) Conjugation position of quercetin glucuronides and effect on biological activity. Free Radic Biol Med 29:1234–1243

    Article  CAS  PubMed  Google Scholar 

  • Day AJ, Mellon F, Barron D, Sarrazin G, Morgan MRA, Williamson G (2001) Human metabolism of dietary flavonoids: identification of plasma metabolites of quercetin. Free Radic Res 35:941–952

    Article  CAS  PubMed  Google Scholar 

  • Deferme S, Gelder J, Augustijns P (2002) Inhibitory effect of fruit extracts on P-glycoprotein related efflux carriers: an in-vitro screening. J Pharm Pharmacol 54:1213–1219

    Article  CAS  PubMed  Google Scholar 

  • Doyle LA, Yang W, Abruzzo LV, Krogmann T, Gao Y, Rishi AK, Ross DD (1998) A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci 95:15665–15670

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Drach D, Zhao S, Drach J, Andreeff M (1995) Low incidence of MDR1 expression in acute promyelocytic leukaemia. Brit J Haematol 90:369–374

    Article  CAS  Google Scholar 

  • Ejendal KFK, Hrycyna CA (2002) Multidrug resistance and cancer: the role of the human ABC transporter ABCG2. Curr Protein Pept Sci 3:503–511

    Article  CAS  PubMed  Google Scholar 

  • Fardel O, Lecureur V, Guillouzo A (1996) The P-glycoprotein multidrug transporter. Gen Pharmacol Vasc Syst 27:1283–1291

    Article  CAS  Google Scholar 

  • Ferry D, Traunecker H, Kerr D (1996) Clinical trials of P-glycoprotein reversal in solid tumours. Eur J Cancer 32:1070–1081

    Article  Google Scholar 

  • Ferté J, Kühnel JM, Chapuis G, Rolland Y, Lewin G, Schwaller MA (1999) Flavonoid-related modulators of multidrug resistance: synthesis, pharmacological activity, and structure-activity relationships. J Med Chem 42:478–489

    Article  PubMed  Google Scholar 

  • Fischer V, Rodríguez-Gascón A, Heitz F, Tynes R, Hauck C, Cohen D, Vickers AEM (1998) The multidrug resistance modulator valspodar (PSC 833) is metabolized by human cytochrome P450 3A. Drug Metab Dispos 26:802–811

    CAS  PubMed  Google Scholar 

  • Fojo T, Bates S (2003) Strategies for reversing drug resistance. Oncogene 22:7512–7523

    Article  CAS  PubMed  Google Scholar 

  • Gerk PM, Vore M (2002) Regulation of expression of the multidrug resistance-associated protein 2 (MRP2) and its role in drug disposition. J Pharmacol Exp Ther 302:407–415

    Article  CAS  PubMed  Google Scholar 

  • Gottesman MM, Fojo T, Bates SE (2002) Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2:48–58

    Article  CAS  PubMed  Google Scholar 

  • Gupta SV, Sass EJ, Davis ME, Edwards RB, Lozanski G, Heerema NA, Lehman A, Zhang X, Jarjoura D, Byrd JC (2011) Resistance to the translation initiation inhibitor silvestrol is mediated by ABCB1/P-glycoprotein overexpression in acute lymphoblastic leukemia cells. AAPS J 13:357–364

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Hadjeri M, Barbier M, Ronot X, Mariotte AM, Boumendjel A, Boutonnat J (2003) Modulation of P-glycoprotein-mediated multidrug resistance by flavonoid derivatives and analogues. J Med Chem 46:2125–2131

    Article  CAS  PubMed  Google Scholar 

  • Haimeur A, Conseil G, Deeley R, Cole S (2004) The MRP-related and BCRP/ABCG2 multidrug resistance proteins: biology, substrate specificity and regulation. Curr Drug Metab 5:21–53

    Article  CAS  PubMed  Google Scholar 

  • Harborne JB, Williams CA (2000) Advances in flavonoid research since 1992. Phytochemistry 55:481–504

    Article  CAS  PubMed  Google Scholar 

  • Hasrat J, Bruyne TD, Backer JP, Vauquelin G, Vlietinck A (1997) Cirsimarin and cirsimaritin, flavonoids of Microtea debilis (Phytolaccaceae) with adenosine antagonistic properties in rats: leads for new therapeutics in acute renal failure. J Pharm Pharmacol 49:1150–1156

    Article  CAS  PubMed  Google Scholar 

  • Havsteen BH (2002) The biochemistry and medical significance of the flavonoids. Pharmacol Ther 96:67–202

    Article  CAS  PubMed  Google Scholar 

  • Hayes JD, Pulford DJ (1995) The glutathione-S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance part II. Crit Rev Biochem Mol 30:521–600

    Article  Google Scholar 

  • Higgins CF (1992) ABC transporters: from microorganisms to man. Ann Rev Cell Biol 8:67–113

    Article  CAS  PubMed  Google Scholar 

  • Holiman PCH, Hertog MGL, Katan MB (1996) Analysis and health effects of flavonoids. Food Chem 57:43–46

    Article  Google Scholar 

  • Hooijberg J, Broxterman H, Scheffer G, Vrasdonk C, Heijn M, De Jong M, Scheper R, Lankelma J, Pinedo H (1999) Potent interaction of flavopiridol with MRP1. Brit J cancer 81:269–276

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Imai Y, Tsukahara S, Asada SSugimoto Y (2004) Phytoestrogens/flavonoids reverse breast cancer resistance protein/ABCG2-mediated multidrug resistance. Cancer Res 64:4346–4352

    Article  CAS  PubMed  Google Scholar 

  • Ishikawa T (1992) The ATP-dependent glutathione S-conjugate export pump. Trends Biochem Sci 17:463–468

    Article  CAS  PubMed  Google Scholar 

  • Jäger W, Gehring E, Hagenauer B, Aust S, Senderowicz A, Thalhammer T (2003) Biliary excretion of flavopiridol and its glucuronides in the isolated perfused rat liver: role of multidrug resistance protein 2 (Mrp2). Life Sci 73:2841–2854

    Article  PubMed  CAS  Google Scholar 

  • Jedlitschky G, Leier I, Buchholz U, Barnouin K, Kurz G, Keppler D (1996) Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump. Cancer Res 56:988–994

    CAS  PubMed  Google Scholar 

  • Juliano RL, Ling V (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 455:152–162

    Article  CAS  PubMed  Google Scholar 

  • Keppler D, Leier I, Jedlitschky G, König J (1998) ATP-dependent transport of glutathione S-conjugates by the multidrug resistance protein MRP1 and its apical isoform MRP2. Chem Biol Interact 111:153–161

    Article  PubMed  Google Scholar 

  • Kimura Y, Matsuo M, Takahashi K, Saeki T, Kioka N, Amachi T, Ueda K (2004) ATP hydrolysis-dependent multidrug efflux transporter: MDR1/P-glycoprotein. Curr Drug Metab 5:1–10

    Article  CAS  PubMed  Google Scholar 

  • Krishna R, Mayer LD (2000) Multidrug resistance (MDR) in cancer: mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs. Eur J Pharm Sci 11:265–283

    Article  CAS  PubMed  Google Scholar 

  • Lee CH (2004) Reversing agents for ATP-binding cassette (ABC) transporters: application in modulating multidrug resistance (MDR). Curr Med Chem 4:43–52

    CAS  Google Scholar 

  • Lehane AM, McDevitt CA, Kirk K, Fidock DA (2011) Degrees of chloroquine resistance in Plasmodium—is the redox system involved? Int J Parasitol Drugs Drug Resist 2:47–57

    Article  PubMed Central  CAS  Google Scholar 

  • Leonessa F, Clarke R (2003) ATP binding cassette transporters and drug resistance in breast cancer. Endocr Relat Cancer 10:43–73

    Article  CAS  PubMed  Google Scholar 

  • Lin JH (2003) Drug-drug interaction mediated by inhibition and induction of P-glycoprotein. Adv Drug Deliv Rev 55:53–81

    Article  CAS  PubMed  Google Scholar 

  • Liscovitch M, Lavie Y (2002) Cancer multidrug resistance: a review of recent drug discovery research. Idrugs 5:349–355

    CAS  PubMed  Google Scholar 

  • Litman T, Druley T, Stein W, Bates S (2001) From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance. Cell Mol Life Sci 58:931–959

    Article  CAS  PubMed  Google Scholar 

  • Loo T, Clarke D (2005) Recent progress in understanding the mechanism of P-glycoprotein-mediated drug efflux. J Membr Biol 206:173–185

    Article  CAS  PubMed  Google Scholar 

  • Maliepaard M, Scheffer GL, Faneyte IF, van Gastelen MA, Pijnenborg ACLM, Schinkel AH, van de Vijver MJ, Scheper RJ, Schellens JHM (2001) Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res 61:3458–3464

    CAS  PubMed  Google Scholar 

  • Mao Q (2005) Role of the breast cancer resistance protein (ABCG2) in drug transport. AAPS J 7:118–133

    Article  Google Scholar 

  • Miyake K, Mickley L, Litman T, Zhan Z, Robey R, Cristensen B, Brangi M, Greenberger L, Dean M, Fojo T (1999) Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells. Cancer Res 59:8–13

    CAS  PubMed  Google Scholar 

  • Morris ME, Zhang S (2006) Flavonoid–drug interactions: effects of flavonoids on ABC transporters. Life Sci 78:2116–2130

    Article  CAS  PubMed  Google Scholar 

  • Morrow CS, Smitherman PK, Townsend AJ (1998) Combined expression of multidrug resistance protein (MRP) and glutathione S-transferase P1-1 (GSTP1-1) in MCF7 cells and high level resistance to the cytotoxicities of ethacrynic acid but not oxazaphosphorines or cisplatin. Biochem Pharmacol 56:1013–1021

    Article  CAS  PubMed  Google Scholar 

  • Mullen W, Graf BA, Caldwell ST, Hartley RC, Duthie GG, Edwards CA, Michael E, Crozier A (2002) Determination of flavonol metabolites in plasma and tissues of rats by HPLC-radiocounting and tandem mass spectrometry following oral ingestion of [2-14C] quercetin-4′-glucoside. J Agric Food Chem 50:6902–6909

    Article  CAS  PubMed  Google Scholar 

  • Newman MJ, Rodarte JC, Benbatoul KD, Romano SJ, Zhang C, Krane S, Moran EJ, Uyeda RT, Dixon R, Guns ES (2000) Discovery and characterization of OC144-093, a novel inhibitor of P-glycoprotein-mediated multidrug resistance. Cancer Res 60:2964–2972

    CAS  PubMed  Google Scholar 

  • Nguyen H, Zhang S, Morris ME (2003) Effect of flavonoids on MRP1-mediated transport in Panc-1 cells. J Pharm Sci 92:250–257

    Article  CAS  PubMed  Google Scholar 

  • Nobili S, Landini I, Mazzei T, Mini E (2011) Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expression. Med Res Rev 32:1220–1262

    Article  PubMed  CAS  Google Scholar 

  • Norman BH (1998) Inhibitors of MRP1-mediated multidrug resistance. Drug Future 23:1001–1014

    Article  CAS  Google Scholar 

  • Nurulita NA, Meiyanto E, Matsuda E, Kawaichi M (2012) Gynura procumbens prevents chemoresistance through inhibition MDR1 expression on MCF-7 breast cancer cell line and sensitizes the cells to doxorubicin. Indones J Biotech 17:51–60

    Google Scholar 

  • O’brien M, Tew K (1996) Glutathione and related enzymes in multidrug resistance. Eur J Cancer 32:967–978

    Article  Google Scholar 

  • Ozben T (2006) Mechanisms and strategies to overcome multiple drug resistance in cancer. FEBS Lett 580:2903–2909

    Article  CAS  PubMed  Google Scholar 

  • Phang JM, Poore CM, Lopaczynska J, Yeh GC (1993) Flavonol-stimulated efflux of 7,12-dimethylbenz(a)anthracene in multidrug-resistant breast cancer cells. Cancer Res 53:5977–5981

    CAS  PubMed  Google Scholar 

  • Pick A, Müller H, Mayer R, Haenisch B, Pajeva IK, Weigt M, Bönisch H, Müller CE, Wiese M (2011) Structure–activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP). Bioorg Med Chem 19:2090–2102

    Article  CAS  PubMed  Google Scholar 

  • Pulido MM, Molina AJ, Merino G, Mendoza G, Prieto JG, Alvarez AI (2006) Interaction of enrofloxacin with breast cancer resistance protein (BCRP/ABCG2): influence of flavonoids and role in milk secretion in sheep. J Vet Pharmacol Ther 29:279–287

    Article  CAS  PubMed  Google Scholar 

  • Rege BD, Kao JPY, Polli JE (2002) Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers. Eur J Pharm Sci 16:237–246

    Article  CAS  PubMed  Google Scholar 

  • Regev R, Assaraf YG, Eytan GD (1999) Membrane fluidization by ether, other anesthetics, and certain agents abolishes P-glycoprotein ATPase activity and modulates efflux from multidrug-resistant cells. Eur J Biochem 259:18–24

    Article  CAS  PubMed  Google Scholar 

  • Regev R, Katzir H, Yeheskely-Hayon D, Eytan GD (2007) Modulation of P-glycoprotein-mediated multidrug resistance by acceleration of passive drug permeation across the plasma membrane. FEBS J 274:6204–6214

    Article  CAS  PubMed  Google Scholar 

  • Rice-Evans C (2001) Flavonoid antioxidants. Curr Med Chem 8:797–807

    Article  CAS  PubMed  Google Scholar 

  • Rosenberg MF, Mao Q, Holzenburg A, Ford RC, Deeley RG, Cole SPC (2001) The structure of the multidrug resistance protein 1 (MRP1/ABCC1). J Biol Chem 276:16076–16082

    Article  CAS  PubMed  Google Scholar 

  • Rosenberg MF, Kamis AB, Callaghan R, Higgins CF, Ford RC (2003) Three-dimensional structures of the mammalian multidrug resistance P-glycoprotein demonstrate major conformational changes in the transmembrane domains upon nucleotide binding. J Biol Chem 278:8294–8299

    Article  CAS  PubMed  Google Scholar 

  • Ross DD, Karp JE, Chen TT, Doyle LA (2000) Expression of breast cancer resistance protein in blast cells from patients with acute leukemia. Blood 96:365–368

    CAS  PubMed  Google Scholar 

  • Salinas AE, Wong MG (1999) Glutathione S-transferases—a review. Curr Med Chem 6:279–310

    CAS  PubMed  Google Scholar 

  • Sauna ZE, Ambudkar SV (2000) Evidence for a requirement for ATP hydrolysis at two distinct steps during a single turnover of the catalytic cycle of human P-glycoprotein. Proc Natl Acad Sci 97:2515–2520

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Sauna ZE, Smith MM, Müller M, Kerr KM, Ambudkar SV (2001) The mechanism of action of multidrug-resistance-linked P-glycoprotein. J Bioenerg Biomembr 33:481–491

    Article  CAS  PubMed  Google Scholar 

  • Sawicka M, Kalinowska M, Skierski J, Lewandowski W (2004) A review of selected anti-tumour therapeutic agents and reasons for multidrug resistance occurrence. J Pharm Pharmacol 56:1067–1081

    Article  CAS  PubMed  Google Scholar 

  • Scambia G, Ranelletti F, Panici PB, Vincenzo R, Bonanno G, Ferrandina G, Piantelli M, Bussa S, Rumi C, Cianfriglia M (1994) Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target. Cancer Chemother Pharmacol 34:459–464

    Article  CAS  PubMed  Google Scholar 

  • Sedlacek H, Czech J, Naik R, Kaur G, Worland P, Losiewicz M, Parker B, Carlson B, Smith A, Senderowicz A (1996) Flavopiridol (L86 8275; NSC 649890), a new kinase inhibitor for tumor therapy. Int J Oncol 9:1143–1168

    CAS  PubMed  Google Scholar 

  • Sergent T, Garsou S, Schaut A, Saeger SD, Pussemier L, Peteghem CV, Larondelle Y, Schneider YJ (2005) Differential modulation of ochratoxin A absorption across Caco-2 cells by dietary polyphenols, used at realistic intestinal concentrations. Toxicol Lett 159:60–70

    Article  CAS  PubMed  Google Scholar 

  • Shapiro AB, Ling V (1997) Effect of quercetin on Hoechst 33342 transport by purified and reconstituted P-glycoprotein. Biochem Pharmacol 53:587–596

    Article  CAS  PubMed  Google Scholar 

  • Shen H, Kauvar L, Tew KD (1997) Importance of glutathione and associated enzymes in drug response. Oncol Res 9:295–302

    CAS  PubMed  Google Scholar 

  • Sparreboom A, Danesi R, Ando Y, Chan J, Figg WD (2003) Pharmacogenomics of ABC transporters and its role in cancer chemotherapy. Drug Resist Update 6:71–84

    Article  CAS  Google Scholar 

  • Spencer JPE, Abd El Mohsen MM, Rice-Evans C (2004) Cellular uptake and metabolism of flavonoids and their metabolites: implications for their bioactivity. Arch Biochem Biophys 423:148–161

    Article  CAS  PubMed  Google Scholar 

  • Stagos D, Amougias G, Matakos A, Spyrou A, Tsatsakis A, Kouretas D (2012) Chemoprevention of liver cancer by plant polyphenols. Food Chem Toxicol 50:2155–2170

    Article  CAS  PubMed  Google Scholar 

  • Starling JJ, Shepard RL, Cao J, Law KL, Norman BH, Kroin JS, Ehlhardt WJ, Baughman TM, Winter MA, Bell MG (1997) Pharmacological characterization of LY335979: a potent cyclopropyldibenzosuberane modulator of P-glycoprotein. Adv Enz Reg 37:335–347

    Article  CAS  Google Scholar 

  • Stavrovskaya A (2000) Cellular mechanisms of multidrug resistance of tumor cells. Biochem Biokhim 65:95–106

    CAS  Google Scholar 

  • Steinbach D, Sell W, Voigt A, Hermann J, Zintl F, Sauerbrey A (2002) BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia. Leukemia 16:1443–1447

    Article  CAS  PubMed  Google Scholar 

  • Suzuki T, Takagi Y, Osanai H, Li L, Takeuchi M, Katoh Y, Kobayashi M, Yamamoto M (2005) Pi class glutathione S-transferase genes are regulated by Nrf 2 through an evolutionarily conserved regulatory element in zebrafish. Biochem J 388:65–73

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Szotáková B, Bártíková H, Hlavácová J, Boušová I, Skálová L (2013) Inhibitory effect of anthocyanidins on hepatic glutathione S-transferase, UDP-glucuronosyltransferase and carbonyl reductase activities in rat and human. Xenobiotica. doi:10.3109/00498254.2012.756557

    PubMed  Google Scholar 

  • Takahata T, Ookawa K, Suto K, Tanaka M, Yano H, Nakashima O, Kojiro M, Tamura Y, Tateishi T, Sakata Y (2008) Chemosensitivity determinants of irinotecan hydrochloride in hepatocellular carcinoma cell lines. Basic Clin Pharmacol Toxicol 102:399–407

    Article  CAS  PubMed  Google Scholar 

  • Tan B, Piwnica-Worms D, Ratner L (2000) Multidrug resistance transporters and modulation. Curr Opin Oncol 12:450–458

    Article  CAS  PubMed  Google Scholar 

  • Tandon VR, Kapoor B, Bano G, Gupta S, Gillani Z, Kour D (2006) P-glycoprotein: pharmacological relevance. Indian J Pharmacol 38:13–24

    Article  CAS  Google Scholar 

  • Teodori E, Dei S, Scapecchi S, Gualtieri F (2002) The medicinal chemistry of multidrug resistance (MDR) reversing drugs. II. Farmaco 57:385–415

    Article  CAS  PubMed  Google Scholar 

  • Tew KD, Gaté L (2001) Glutathione-S-transferases as emerging therapeutic targets. Expert Opin Ther Target 5:477–489

    Article  Google Scholar 

  • Thomas H, Coley HM (2003) Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting P-glycoprotein. Cancer Control 10:159

    PubMed  Google Scholar 

  • Tombline G, Bartholomew L, Gimi K, Tyndall GA, Senior AE (2004) Synergy between conserved ABC signature Ser residues in P-glycoprotein catalysis. J Biol Chem 279:5363–5373

    Article  CAS  PubMed  Google Scholar 

  • Townsend DM, Tew KD (2003) The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene 22:7369–7375

    Article  CAS  PubMed  Google Scholar 

  • Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y (1981) Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res 41:1967–1972

    CAS  PubMed  Google Scholar 

  • van Bladeren PJ, Van Ommen B (1991) The inhibition of glutathione-S-transferases: mechanisms, toxic consequences and therapeutic benefits. Pharmacol Ther 51:35–46

    Article  PubMed  Google Scholar 

  • Van Zanden JJ (2005) Modulation of multidrug resistance by flavonoids. Inhibitors of glutathione conjugation and MRP-mediated transport. Dissertation, Wageningen University, Wageningen, The Netherlands

  • Van Zanden JJ, Ben Hamman O, Van Iersel MLPS, Boeren S, Cnubben NHP, Lo Bello M, Vervoort J, van Bladeren PJ, Rietjens IMCM (2003) Inhibition of human glutathione S-transferase P1-1 by the flavonoid quercetin. Chem-Biol Interact 145:139–148

    Article  PubMed  CAS  Google Scholar 

  • Van Zanden JJ, Geraets L, Wortelboer HM, Bladeren PJ, Rietjens IMCM, Cnubben NHP (2004) Structural requirements for the flavonoid-mediated modulation of glutathione-S-transferase P1-1 and GS-X pump activity in MCF7 breast cancer cells. Biochem Pharmacol 67:1607–1617

    Article  PubMed  CAS  Google Scholar 

  • Van Zanden JJ, Wortelboer HM, Bijlsma S, Punt A, Usta M, Bladeren PJv, Rietjens IM, Cnubben NH (2005) Quantitative structure activity relationship studies on the flavonoid mediated inhibition of multidrug resistance proteins 1 and 2. Biochem Pharmacol 69:699–708

    Article  PubMed  CAS  Google Scholar 

  • Van Zanden JJ, van der Woude H, Vaessen J, Usta M, Wortelboer HM, Cnubben NHP, Rietjens IMCM (2007) The effect of quercetin phase II metabolism on its MRP1 and MRP2 inhibiting potential. Biochem Pharmacol 74:345–351

    Article  PubMed  CAS  Google Scholar 

  • Van Zuylen L, Nooter K, Sparreboom A, Verweij J (2000) Development of multidrug-resistance convertors: sense or nonsense? Invest New Drug 18:205–220

    Article  Google Scholar 

  • Varma MVS, Ashokraj Y, Dey CS, Panchagnula R (2003) P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement. Pharmacol Res 48:347–359

    Article  CAS  PubMed  Google Scholar 

  • Veeriah S, Kautenburger T, Habermann N, Sauer J, Dietrich H, Will F, Pool-Zobel BL (2006) Apple flavonoids inhibit growth of HT29 human colon cancer cells and modulate expression of genes involved in the biotransformation of xenobiotics. Mol Carcinog 45:164–174

    Article  CAS  PubMed  Google Scholar 

  • Versantvoort C, Schuurhuis G, Pinedo H, Eekman C, Kuiper C, Lankelma J, Broxterman H (1993) Genistein modulates the decreased drug accumulation in non-P-glycoprotein mediated multidrug resistant tumour cells. Brit J Cancer 68:939–946

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Versantvoort CHM, Broxterman HJ, Lankelma J, Pinedo HM (1994) Competitive inhibition by genistein and ATP dependence of daunorubicin transport in intact MRP overexpressing human small cell lung cancer cells. Biochem Pharmacol 48:1129–1136

    Article  CAS  PubMed  Google Scholar 

  • Wang X, Morris ME (2007) Effects of the flavonoid chrysin on nitrofurantoin pharmacokinetics in rats: potential involvement of ABCG2. Drug Metab Dispos 35:268–274

    Article  CAS  PubMed  Google Scholar 

  • Wesołowska O, Wiśniewski J, Środa-Pomianek K, Bielawska-Pohl A, Paprocka M, Duś D, Nl Duarte, Ferreira M-JU, Michalak K (2012) Multidrug resistance reversal and apoptosis induction in human colon cancer cells by some flavonoids present in citrus plants. J Nat Prod 75:1896–1902

    Article  PubMed  CAS  Google Scholar 

  • Williamson G, Aeberli I, Miguet L, Zhang Z, Sanchez MB, Crespy V, Barron D, Needs P, Kroon PA, Glavinas H (2007) Interaction of positional isomers of quercetin glucuronides with the transporter ABCC2 (cMOAT, MRP2). Drug Metab Dispos 35:1262–1268

    Article  CAS  PubMed  Google Scholar 

  • Wu H, Hait WN, Yang JM (2003) Small interfering RNA-induced suppression of MDR1 (P-glycoprotein) restores sensitivity to multidrug-resistant cancer cells. Cancer Res 63:1515–1519

    CAS  PubMed  Google Scholar 

  • Yáñez JA, Remsberg CM, Takemoto JK, Vega-Villa KR, Andrews PK, Sayre CL, Martinez SE, Davies NM (2013) Polyphenols and flavonoids: an overview. Flavonoid pharmacokinetics: methods of analysis, preclinical and clinical pharmacokinetics, safety, and toxicology. Wiley, New Jersey, pp 1–69

    Google Scholar 

  • Zhang S, Yang X, Morris ME (2004) Flavonoids are inhibitors of breast cancer resistance protein (ABCG2)-mediated transport. Mol Pharmacol 65:1208–1216

    Article  CAS  PubMed  Google Scholar 

  • Zhang L, Lin G, Kovács B, Jani M, Krajcsi P, Zuo Z (2007) Mechanistic study on the intestinal absorption and disposition of baicalein. Eur J Pharm Sci 31:221–231

    Article  PubMed  CAS  Google Scholar 

  • Zhou S, Lim LY, Chowbay B (2004) Herbal modulation of P-glycoprotein. Drug Metab Rev 36:57–104

    Article  CAS  PubMed  Google Scholar 

  • Zhou L, Jing Y, Styblo M, Chen Z, Waxman S (2005) Glutathione-S-transferase π inhibits As2O3-induced apoptosis in lymphoma cells: involvement of hydrogen peroxide catabolism. Blood 105:1198–1203

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Authors are grateful to Prof. P. Ramarao, Dean Academic and Centre Coordinator of Centre for Chemical and Pharmaceutical Sciences for guiding and positive feedback during the course of the work. Authors are also thankful to Vice-Chancellor for providing necessary facilities at Central University of Punjab, Bathinda.

Author information

Authors and Affiliations

  1. Centre for Chemical and Pharmaceutical Sciences, School of Basic and Applied Sciences, Central University of Punjab, Bathinda, 151001, India

    Vinay Kumar Gupta, Yashika Bhalla & Vikas Jaitak

Authors
  1. Vinay Kumar Gupta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yashika Bhalla
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Vikas Jaitak
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vikas Jaitak.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gupta, V.K., Bhalla, Y. & Jaitak, V. Impact of ABC transporters, glutathione conjugates in MDR and their modulation by flavonoids: an overview. Med Chem Res 23, 1–15 (2014). https://doi.org/10.1007/s00044-013-0612-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00044-013-0612-6

Keywords

Search

Navigation